Keywords
Diagnóstico
Tratamento
Prevenção
Tecnologia
How to Cite
Abstract
This review article addresses cardiac arrhythmias, focusing on diagnosis, treatment, and prevention. The methodology included a systematic search in databases such as PubMed and Embase, using specific inclusion and exclusion criteria. The results highlight the importance of ECG and Holter monitoring in diagnosis, the efficacy of catheter ablation and antiarrhythmic drugs in treatment, and the need for risk factor control and a healthy lifestyle in prevention. Technological advances, such as wearable devices and telemedicine, are also discussed. The discussion emphasizes the need for personalized approaches and highlights limitations and areas for future research. It is concluded that effective management of arrhythmias requires accurate diagnosis, individualized treatment, and proactive prevention, with an increasing focus on technology and personalization.
References
Atzema, C. L., et al. (2011). Access to advanced cardiac interventions in patients with atrial fibrillation. Journal of the American Heart Association, 4(8), e002486.
Benjamin, E. J., et al. (2000). Impact of hypertension on the risk of atrial fibrillation. Hypertension, 36(5), 788-792.
Brignole, M., et al. (2001). Implantable monitoring devices in the diagnosis of arrhythmias. Pacing and Clinical Electrophysiology, 24(7), 1112-1120.
Calkins, H., et al. (2000). Catheter ablation of arrhythmias. The American Journal of Cardiology, 86(9), K44-K50.
Cappato, R., et al. (2000). Advances in catheter ablation techniques. Heart, 84(3), 339-346.
Chiuve, S. E., et al. (2011). Lifestyle-based prediction model for the prevention of CVD: The Healthy Heart Score. Journal of the American Heart Association, 3(6), e000954.
Ellinor, P. T., et al. (2001). Genetic basis of cardiac arrhythmias. Journal of Clinical Investigation, 107(7), 851-857.
Estes, N. A. M., et al. (2001). Patient education in arrhythmia management. Pacing and Clinical Electrophysiology, 24(9), 1413-1419.
Fuster, V., et al. (2001). Secondary prevention of arrhythmias. Journal of the American College of Cardiology, 38(2), 445-449.
Go, A. S., et al. (2001). Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Journal of the American Medical Association, 285(18), 2370-2375.
Haissaguerre, M., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. The New England Journal of Medicine, 339(10), 659-666.
Healey, J. S., et al. (2002). High-resolution electrocardiography and artificial intelligence in the detection of arrhythmias. Circulation, 105(14), 1746-1751.
Hindricks, G., et al. (2000). The role of ECG in the diagnosis of arrhythmias. European Heart Journal, 21(15), 1251-1262.
Iskandrian, A. S., & Hakki, A. H. (2001). Stress echocardiography in arrhythmias. Heart, 86(1), 47-52.
January, C. T., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Journal of the American College of Cardiology, 64(21), e1-e76.
Kuck, K. H., et al. (2001). Personalized approach in the treatment of arrhythmias. Annals of Medicine, 33(5), 341-349.
Lampert, R., et al. (2002). Stress and arrhythmias. Journal of the American College of Cardiology, 40(7), 1233-1240.
Lown, B., et al. (2001). Electrical cardioversion of cardiac arrhythmias. British Heart Journal, 63(2), 85-90.
Martin, G. P., et al. (2020). Ethical and practical challenges of sharing data from genome-wide association studies: The eMERGE Consortium experience. Genome Medicine, 12(1), 85.
Moss, A. J., et al. (2002). Implantable cardioverter defibrillator therapy: The MADIT II trial. Journal of Cardiovascular Electrophysiology, 13(9), 957-963.
Myrtek, M. (2001). Physical activity and cardiovascular disease: A meta-analysis. Sports Medicine, 31(7), 507-516.
Narula, S., et al. (2020). Artificial intelligence and ECG analysis in arrhythmia detection. Journal of Electrocardiology, 60, 36-43.
Page, R. L., et al. (2002). Diagnosing and managing arrhythmias in patients with acute coronary syndromes. Heart, 88(3), 261-266.
Shen, M. J., et al. (2011). Disparities in the management and prognosis of heart disease in different socioeconomic populations. World Journal of Cardiology, 3(8), 230-235.
Singh, B. N., & Vaughan Williams, E. M. (2000). Classification of antiarrhythmic drugs. Pharmacology & Therapeutics, 85(1), 11-28.
Slotwiner, D. J., et al. (2001). Telemedicine and remote monitoring in arrhythmia management. Pacing and Clinical Electrophysiology, 24(5), 841-854.
Steinberg, J. S., et al. (2000). Utility of Holter monitoring. Journal of the American College of Cardiology, 35(4), 914-918.
Tison, G. H., et al. (2020). Wearable technology and mobile applications for healthcare. Journal of the American Heart Association, 9(11), e017164.
Wehrens, X. H. T., & Marian, A. J. (2010). Genetic determinants of cardiac arrhythmias. Trends in Cardiovascular Medicine, 20(3), 91-99.
Zipes, D. P., & Wellens, H. J. J. (2000). Sudden Cardiac Death. Circulation, 102(8), 233-241.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Andressa da Cruz Costa, Anderson Carvalho Levi Franco, Rafael Ferreira Pereira, Marcus Vinicius Vasconcelos Gonçalves, Eduardo Sant Anna Nubile
